The global unfractionated heparin market continues to play a vital role in the healthcare industry due to the widespread use of anticoagulants in preventing and treating thromboembolic disorders. Unfractionated heparin (UFH) remains one of the most commonly used anticoagulant therapies in hospitals and clinical settings because of its rapid onset of action, established safety profile, and...